Corvus Pharmaceuticals CRVS Proceeds From Pre Funded Warrants Financing Activities
Proceeds From Pre Funded Warrants Financing Activities at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept crvs:ProceedsFromPreFundedWarrantsFinancingActivities.
The official record: Corvus Pharmaceuticals’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's proceeds from pre funded warrants financing activities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's proceeds from pre funded warrants financing activities?
- Corvus Pharmaceuticals (CRVS) reported proceeds from pre funded warrants financing activities of $1.26M in Q4 2024.
- What does proceeds from pre funded warrants financing activities mean?
- This represents cash inflows received from the issuance of pre-funded warrants, which are instruments that allow holders to acquire common stock at a nominal exercise price. These are often used in capital raises to provide immediate liquidity while deferring the formal issuance of shares. It serves as a measure of the company's ability to secure non-dilutive or pre-emptive capital from institutional investors.